1. Home
  2. GNFT vs FSFG Comparison

GNFT vs FSFG Comparison

Compare GNFT & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • FSFG
  • Stock Information
  • Founded
  • GNFT 1999
  • FSFG 2008
  • Country
  • GNFT France
  • FSFG United States
  • Employees
  • GNFT N/A
  • FSFG N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • FSFG Savings Institutions
  • Sector
  • GNFT Health Care
  • FSFG Finance
  • Exchange
  • GNFT Nasdaq
  • FSFG Nasdaq
  • Market Cap
  • GNFT 172.2M
  • FSFG N/A
  • IPO Year
  • GNFT 2019
  • FSFG 2008
  • Fundamental
  • Price
  • GNFT $3.60
  • FSFG $25.79
  • Analyst Decision
  • GNFT Strong Buy
  • FSFG Buy
  • Analyst Count
  • GNFT 1
  • FSFG 1
  • Target Price
  • GNFT $13.00
  • FSFG $31.00
  • AVG Volume (30 Days)
  • GNFT 3.9K
  • FSFG 14.0K
  • Earning Date
  • GNFT 09-19-2024
  • FSFG 01-28-2025
  • Dividend Yield
  • GNFT N/A
  • FSFG 2.34%
  • EPS Growth
  • GNFT N/A
  • FSFG 66.39
  • EPS
  • GNFT 0.47
  • FSFG 1.98
  • Revenue
  • GNFT $86,225,222.00
  • FSFG $68,091,000.00
  • Revenue This Year
  • GNFT $145.20
  • FSFG N/A
  • Revenue Next Year
  • GNFT N/A
  • FSFG $2.77
  • P/E Ratio
  • GNFT $7.58
  • FSFG $12.97
  • Revenue Growth
  • GNFT 175.45
  • FSFG N/A
  • 52 Week Low
  • GNFT $3.35
  • FSFG $14.55
  • 52 Week High
  • GNFT $6.42
  • FSFG $30.94
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 42.09
  • FSFG 39.69
  • Support Level
  • GNFT $3.35
  • FSFG $24.24
  • Resistance Level
  • GNFT $3.66
  • FSFG $26.12
  • Average True Range (ATR)
  • GNFT 0.10
  • FSFG 0.78
  • MACD
  • GNFT 0.03
  • FSFG 0.05
  • Stochastic Oscillator
  • GNFT 45.45
  • FSFG 20.20

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: